Acanthamoeba Keratitis Treatment
For Acanthamoeba keratitis, initiate immediate treatment with polyhexamethylene biguanide (PHMB) 0.02% plus propamidine 0.1% combination therapy, or alternatively PHMB 0.06-0.08% monotherapy, and critically—avoid corticosteroids entirely as they are associated with treatment failure and poor visual outcomes 1, 2, 3, 4.
Initial Treatment Regimen
The evidence strongly supports biguanide-based therapy as first-line treatment:
PHMB 0.02% + propamidine 0.1% combination: The ODAK trial demonstrated similar 12-month cure rates between PHMB 0.08% monotherapy and PHMB 0.02% plus propamidine 0.1% combination, with both achieving better-than-expected outcomes using standardized protocols 2
PHMB 0.06% monotherapy: Recent data shows 91.9% medical cure rate with this regimen, with only 4.7% overall treatment failure 4
Chlorhexidine 0.02% + propamidine 0.1%: Comparable efficacy to PHMB-based regimens, with all stage 1-2 disease achieving medical resolution. Average treatment duration was shorter (118 vs 233 days) compared to PHMB, though this may reflect earlier diagnosis in that cohort 3
Critical Management Principles
Absolute Contraindication to Corticosteroids
Corticosteroids must be avoided in suspected or confirmed Acanthamoeba keratitis 1. The evidence is unequivocal:
- All 12 treatment failures in one series occurred in patients who received corticosteroids prior to diagnosis 3
- Prior steroid use is a significant poor prognostic factor for visual outcomes (P < 0.0002) 4
- Guidelines explicitly state corticosteroids should be avoided in cases of suspected Acanthamoeba 1
If a patient is already on topical corticosteroids when AK is suspected, immediately discontinue or eliminate the corticosteroid regimen 1.
Disease Stage and Prognosis
Treatment success correlates directly with disease stage at presentation:
- Stage 1-2 disease: 100% medical cure rate achievable with either PHMB or chlorhexidine-based regimens 3
- Stage 3 disease: 75% (12/16 patients) required therapeutic keratoplasty, representing treatment failure 3
Poor Prognostic Factors to Recognize
- Prediagnosis steroid use (P < 0.0002)
- Disease relapse (P < 0.0001)
- Scleritis (P < 0.0001)
- Ring infiltrate at diagnosis (P < 0.02)
- Delayed diagnosis (P < 0.03)
- Older patient age 3, 4
Diagnostic Approach
The median time from symptom onset to diagnosis is 30 days, and only 6.7% are correctly diagnosed at initial presentation—most commonly misdiagnosed as bacterial keratitis (48.3%) 4. Therefore, maintain high clinical suspicion in:
- Contact lens wearers with water exposure (71.2% of cases): swimming, hot tubs, showering with lenses, tap water rinsing 4
- Patients not responding to standard bacterial keratitis treatment
- Severe pain disproportionate to clinical findings
Diagnostic Testing Sensitivity
When compared to composite reference standards 4:
- In vivo confocal microscopy (IVCM): 97% sensitivity—most sensitive test
- PCR: 49% sensitivity
- Microbial culture: 13% sensitivity
Clinical judgment based on risk factors remains essential when IVCM is unavailable, as delayed diagnosis significantly worsens visual outcomes 4.
Treatment Duration and Monitoring
- Average treatment duration: 118-233 days depending on regimen and disease stage 3
- Intensive topical therapy required initially
- Close follow-up mandatory to assess response and adjust therapy
- Treatment success defined as resolution of infection without need for therapeutic keratoplasty
Surgical Management
- Therapeutic keratoplasty indicated for stage 3 disease unresponsive to medical therapy
- Overall surgical intervention needed in 2.7% of cases to achieve treatment success 4
- Optimal timing remains uncertain, but typically reserved for medical treatment failures 2
Adjunctive Therapies
Evidence is limited to observational studies and small trials, but potential adjuncts include 2:
- Topical voriconazole
- Rose Bengal Photodynamic Antimicrobial Therapy
- Miltefosine
- Povidone-iodine
These should be considered only as adjuncts to standard biguanide-based therapy, not as primary treatment.
Common Pitfall
The most critical error is using corticosteroids before ruling out Acanthamoeba keratitis. In any contact lens wearer with keratitis, especially with water exposure history, assume Acanthamoeba until proven otherwise and withhold steroids 1, 3, 4.